Aspirin Dosing in Cardiovascular Disease
N Engl J Med
.
2021 Aug 19;385(8):764.
doi: 10.1056/NEJMc2110476.
Authors
Paul A Monach
1
,
Westyn Branch-Elliman
1
Affiliation
1
VA Boston Healthcare System, Boston, MA paul.monach@va.gov.
PMID:
34407351
DOI:
10.1056/NEJMc2110476
No abstract available
Publication types
Letter
Comment
MeSH terms
Aspirin
Cardiovascular Diseases* / drug therapy
Cardiovascular Diseases* / prevention & control
Humans
Platelet Aggregation Inhibitors / adverse effects
Substances
Platelet Aggregation Inhibitors
Aspirin